Media Thread, page-7200

Well, my friend, I have alway avoided calculating potential valuations for Imugene because the numbers can look insanely high and I feel uncomfortable about that. Not saying it couldn't happen, but this is still speculative territory.

However, I have just bought a whole lot more at 0.195 because fundamentally I agree with you that it is "going cheap" at anything under 20 cents.

I was considering entry into another biotech with a far lower market cap but I do feel that - even putting aside "blue sky" valuations - Imugene has real multi-bagger potential at far lower risk than my other potential buy. I'm also pretty confident that there is a major turn around in the share price coming in the near term.

Sure I could be wrong, but I feel the market has over sold Imugene through sheer impatience - and also partly because of international uncertainty and fear - just when the news flow is about to vindicate their work.

We will see...

Cheer

Dave